This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Redd SC. SCsthma in the United States: burden and current theories. Environ Health Perspect 2002;110(Suppl 4):557–560.
Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. WB national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997;156:787–793.
Lozano P, Sullivan SD, Smith DH, Weiss KB. KBhe economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 1999;104:957–963.
Weitzman M, Gortmaker SL, Sobol AM, Perrin JM. JMecent trends in the prevalence and severity of childhood asthma. JAMA 1992;268:2673–2677.
Control CfD. CfDsthma mortality and hospitalization among children and young adults: United States, 1980–1993. JAMA 1996;275:1535– 1537.
Goodman DC, Stukel TA, Chang C. Crends in pediatric asthma hospitalization rates: regional and socioeconomic differences. Pediatrics 1998;101:208–213.
Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. SCurveillance for asthma: United States, 1980–1999. Morbid Mortal Wkly Rep CDC Surveill Summ 2002;51:1–13.
Mannino DM, Homa DM, Pertowski CA, Ashizawa A, Nixon LL, Johnson CA, et al. Surveillance for asthma: United States, 1960–1995. Morbid Mortal Wkly Rep CDC Surveill Summ 1998;47:1–27.
Akinbami LJ, Schoendorf KC. KCrends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002;110:315–322.
Pirie J, Cox P, Johnson D, Schuh S. Shanges in treatment and outcomes of children receiving care in the intensive care unit for severe acute asthma. Pediatr Emerg Care 1998;14:104–108.
Paret G, Kornecki A, Szeinberg A, Vardi A, Barzilai A, Augarten A, et al. Severe acute asthma in a community hospital pediatric intensive care unit: a ten years’ experience. Ann Allergy Asthma Immunol 1998;80:339–344.
Osundwa VM, Dawod S. Sour-year experience with bronchial asthma in a pediatric intensive care unit. Ann Allergy 1992;69:518–520.
Stein R, Canny GJ, Bohn DJ, Reisman JJ, Levison H. Hevere acute asthma in the pediatric intensive care unit: six years’ experience. Pediatrics 1989;83:1023–1028.
Shugg AW, Kerr S, Butt WW. WWechanical ventilation of paediatric patients with asthma: short and long term prognosis. J Paediatr Child Health 1990;26:343–346.
Russo MJ, McConnochie KM, McBride JT, Szilagyi PG, Brooks AM, Roghmann KJ. KJncrease in admission threshold explains stable asthma hospitalization rates. Pediatrics 1999;104(3?Pt 1):454–462.
Sly RM. RMecrease in asthma mortality in the United States. Ann Allergy Asthma Immunol 2000;85:121–127.
Wennergren G, Strannegard IL. ILsthma hospitalizations continue to decrease in schoolchildren but hospitalization rates for wheezing remain high in young children. Acta Paediatr 2002;91:1239–1245.
Committee TIS. TISnternational Survey of Asthma and Allergy in Childhood: worldwide variation in prevalence of symptoms of asthma, allergic conjunctivitis, and atopic eczema. Lancet 1998;351:1225–1232.
Burney P, Chinn S, Jarvis D. Dariations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687–695.
Keller MB, Lowenstein SR. SRpidemiology of asthma. Semin Respir Crit Care Med 2002;23:317–329.
Elias JA, Lee CG, Ma B, Homer RJ, Zhu Z. Zew insights into the pathogenesis of asthma. J Clin Invest 2003;111:291–297.
Van Niekerk CH, Weinberg EG, Shore SC, Heese HV, Van Schalkwyk J. Prevalence of asthma: a comparative study of urban and rural Xhosa children. Clin Allergy 1979;9:319–324.
Von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. Uncreasing prevalence of hay fever and atopy in Leipzig, East Germany. Lancet 1998;351:862–866.
Schwartz J, Gold D, Dockery DW, Weiss ST, Speizer FE. FEredictors of asthma and persistent wheeze in a national sample of children in the United States: association with social class, perinatal events, and race. Am Rev Respir Dis 1990;142:555–562.
Lwebuga-Mukasa JS, Dunn-Georgious E. The prevalence of asthma in children of elementary school age in western New York. J Urban Health 2000;77:745–761.
Ernst P, Habbick B, Suissa S, Hemmelgarn B, Cockroft D, Buist AS, et al. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis 1993;148:75–79.
Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J 1994;7:1602–1609.
Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149:604–610.
McFadden ER, Jr. The beta2-agonist controversy revisited. Ann Allergy Asthma Immunol 1995;75:173–176.
Rea HH, Garrett JE, Lanes SF, Birmann BM, Kolbe J. Jhe association between asthma drugs and severe life-threatening attacks. Chest 1996;110:1446–1451.
Lanes SF, Birmann B, Raiford D, Walker AM. AMnternational trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970–1992. J Clin Epidemiol 1997;50:321–328.
Williams C, Crossland L, Finnerty J, Crane J, Holgate S, Pearce N, et al. Case–control study of salmeterol and near-fatal attacks of asthma. Thorax 1998;53:7–13.
Sears MR, Rea HH, Beaglehole R, Gillies AJ, Holst PE, O’Donnell TV, et al. Deaths from asthma in New Zealand. N Z Med J 1985;98: 271–275.
Sears MR, Rea HH, Fenwick J, Beaglehole R, Gillies AJ, Holst PE, et al. Deaths from asthma in New Zealand. Arch Dis Child 1986;61:6–10.
Sears MR, Rea HH, Rothwell RP, O’Donnell TV, Holst PE, Gillies AJ, et al. Asthma mortality comparison between New Zealand and England. BMJ 1986;293:1342–1345.
Ernst P, Spitzer WO, Suissa S, Cockroft D, Habbick B, Horwitz RI, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroids use. JAMA 1992;268:3462–3464.
Suissa S, Ernst P. Pptical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. J Clin Epidemiol 1997;50:1079–1088.
Suissa S, Ernst P. Pnhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001;107:937–944.
Suissa S, Ernst P, Benvanoun S, Baltzan M, Cai B. Bow-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332–336.
Papiris S, Kotanidou A, Malagari K, Roussols C. Clinical review: severe asthma. Critical Care 2002;6:30–44.
McFadden ER, Jr., Warren EL. Observations on asthma mortality. Ann Intern Med 1997;127:142–147.
Benatar SR. SRatal asthma. N Engl J Med 1986;314:423–429.
McFadden ER, Jr. Fatal and near-fatal asthma. N Engl J Med 1991; 324:409–411.
Association BT. BTeath due to asthma. BMJ 1982;285:1251–1255.
Molfino NA, Nannini LJ, Martelli AN, Slutsky AS. ASespiratory arrest in near-fatal asthma. N Engl J Med 1991;324:285–288.
Strunk RC. RCudden death in asthma. Am J Respir Crit Care Med 1993;148:550–552.
Strunk RC. RCdentification of the fatality-prone subject with asthma. J Allergy Clin Immunol 1989;83:477–485.
DeNicola LK, Monem GF, Gayle MO, Kissoon N. Nreatment of critical status asthmaticus in children. Pediatr Clin North Am 1994;41(6): 1293–324.
Wasserfallen J-B, Schaller M-D, Feihl F, Perret CH. CHudden asphyxic asthma: a distinct entity? Am Rev Respir Dis 1990;142:108–111.
Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am J Respir Crit Care Med 1993;148:713–719.
Maffei FA, van der Jagt EW, Powers KS, Standage SW, Connolly HV, Harmon WG, et al. Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroup. Pediatrics 2004;114(3):762–767.
Reid LM. LMhe presence or absence of bronchial mucus in fatal asthma. J Allergy Clin Immunol 1987;80(Suppl):415–419.
Robertson CF, Rubinfeld AR, Bowes G. Gediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol 1992;13:95–100.
Kravis LP, Kolski GB. GBnexpected death in childhood asthma. A review of 13 deaths in ambulatory patients. Am J Dis Child 1985; 139(6):558–563.
Fletcher HJ, Ibrahim SA, Speight N. Nurvey of asthma deaths in the northern region, 1970–1985. Arch Dis Child 1990;65:163–167.
Matsui T, Baba M. Meath from asthma in children. Acta Paediatr Jpn 1990;32:205–208.
Mountain RD, Sahn SA. SAlinical features and outcome in patients with acute asthma presenting with hypercapnia. Am Rev Respir Dis 1988;138:535–539.
Strunk RC, Mrazek DA, Fuhrman GS, LaBrecque JF. JFhysiologic and psychological characteristics associated with deaths due to asthma in childhood: a case–controlled study. JAMA 1985;254:1193–1198.
Strunk RC, Mrazek DA. DAeaths from asthma in childhood: can they be predicted? N Engl Reg Allergy Proc 1986;7:454–461.
Birkhead G, Attaway NJ, Strunk RC, Townsend MC, Teutsch S. Snvestigation of a cluster of deaths of adolescents from asthma: evidence implicating inadequate treatment and poor patient adherence with medications. J Allergy Clin Immunol 1989;84(4?pt 1):484–491.
Martin AJ, Campbell DA, Gluyas PA, Coates JR, Ruffin RE, Roder DM, et al. Characteristics of near-fatal asthma in childhood. Pediatr Pulmonol 1995;20:1–8.
Patterson R, Greenberger PA, Patterson DR. DRotentially fatal asthma: the problem of noncompliance. Ann Allergy 1991;67(2?pt 1):138–142.
Werner HA. HAtatus asthmaticus in children: a review. Chest 2001; 119:1913–1929.
Male I, Richter H, Seddon P. Phildren’s perception of breathlessness in acute asthma. Arch Dis Child 2000;83:325–329.
Belessis Y, Dixon S, Thomsen A, Duffy B, Rawlinson W, Henry R, et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr Pulmonol 2004;37:201–209.
Thomas M, Griffths C. Csthma and panic: scope for intervention? Am J Respir Crit Care Med 2005;171:1197–1198.
Steinman RM. RMhe dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991;9:271–296.
Banchereau J, Steinman RM. RMendritic cells and the control of immunity. Nature 1998;392:245–252.
Sertl K, Takemura T, Tschachler E, Ferrans VJ, Kaliner MA, Shevach EM. EMendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med 1986;163:436–451.
Holt PG, Schon-Hegrad MA. Localization of T cells, macrophages, and dendritic cells in rat respiratory tract tissue: implications for immune function studies. Immunology 1987;62:349–356.
Havenith CE, Van MPP, Breedijk AJ, Beelen RH, Hoefsmit EC. ECigration of dendritic cells into the draining lymph nodes of the lung after intratracheal instillation. Am J Respir Cell Mol Biol 1993;9:484–488.
Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. RAendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998;160:4090–4097.
Kay AB. ABllergy and allergic diseases. N Engl J Med 2001;344:30–37.
Prescott SL. SLew concepts of cytokines in asthma: is the Th2/Th1 paradigm out the window? J Paediatr Child Health 2003;39:575–579.
Busse WW, Lemanske J, R.F. Asthma. N Engl J Med 2001;344:350–362.
Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD. MDelation between airway responsiveness and serum IgG in children with asthma and apparently normal children. N Engl J Med 1991;325:1067–1071.
Beeh KM, Ksoll M, Buhl R. Rlevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals. Eur Respir J 2000;16:609–614.
Kaliner MA, Blennerhassett J, Austen FK, eds. Bronchial Asthma. New York: Grune and Stratton; 1976.
Gerblich AA, Salik H, Schuyler MR. MRynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen provocation in asthmatics. Am Rev Respir Dis 1991;143:533–539.
Wills-Karp M. Immunologic basic of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255–281.
Cox G, Ohtoshi T, Vancheri C, Denburg JA, Dolovich J, Gauldie J, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991;4:525–531.
Cox G, Gauldie J, Jordana M. Mronchial epithelial cell–derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992;7:507–513.
Xing Z, Ohtoshi T, Ralph P, Gauldie J, Jordana M. Muman upper airway structural cell-derived cytokines support human peripheral blood monocyte survival: a potential mechanism for monocyte/macrophage accumulation in the tissue. Am J Respir Cell Mol Biol 1992;6:212–218.
Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulmonol Med 2005;11:35–42.
Miller AL, Lukacs NW. NWhemokine receptors: understanding their role in asthmatic disease. Immunol Allergy Clin North Am 2004; 24:667–683.
Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. ADignal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 2001;193(9):1087–1096.
Mathew A, Medoff BD, Carafone AD, Luster AD. ADutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J Immunol 2002;169(2):651–655.
Ennis M. Meutrophils in asthma pathophysiology. Curr Allergy Asthma Rep 2003;3:159–165.
Chung KF. KFirway smooth muscle cells: contributing to and regulating airway mucosal inflammation? Eur Respir J 2000;15:961–968.
Hakonarson H, Carter C, Kim C, Grunstein MM. MMltered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle. J Allergy Clin Immunol 1999;104: 575–584.
Hakonarson H, Kim C, Whelan R, Campbell D, Grunstein MM. MMi-directional activation between human airway smooth muscle cells and T lymphocytes: role in induction of altered airway responsiveness. J Immunol 2001;166:293–303.
Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howart P, Redington A, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510–1513.
DeNicola LK, Kissoon N, Duckworth LJ, Blake KV, Murphy SP, Silkoff PE. PExhaled nitric oxide as an indicator of severity of asthmatic inflammation. Pediatr Emerg Care 2000;16:290–295.
Lanz MJ, Leung DY, White CW. CWomparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children. Ann Allergy Asthma Immunol 1999;82:161–164.
Baraldi E, Dario C, Ongaro R, Scollo M, Azzolin NM, Panza N, et al. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am J Respir Crit Care Med 1999;159:1284–1288.
Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. JMxpired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995;152:800–803.
Nelson BV, Sears S, Woods J, Ling CY, Hunt J, Clapper LM, et al. Expired nitric oxide as a marker for childhood asthma. J Pediatr 1997;130:423–427.
Murray AB, Ferguison AC, Morrison B. Birway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1981;68:119–124.
O’Byrne PM, Inman MD. MDirway hyperresponsiveness. Chest 2003;123:411S–416S.
Lee YM, Park JS, Hwang JH, Park SW, Uh ST, Kim YH, et al. High-resolution CT findings in patients with near-fatal asthma: comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004;126:1840–1848.
Metcalfe DD, Baram D, Mekori YA. YAast cells. Physiol Rev 1997;77: 1033–1079.
Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann F, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1828–1824.
Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JB, Kurup VP, Martin TR, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997;94:1344–1349.
Holtzmann MJ, Morton JD, Shornick LP, Tyner JW, O’Sullivan MP, Antao A, et al. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial–viral–allergic paradigm. Physiol Rev 2002;82:19–46.
Reed CE. CEhe natural history of asthma in adults: the problem of irreversibility. J Allergy Clin Immunol 1999;103:539–547.
Holgate ST, Lackie P, Wilson S, Roche W, Davis D. Dronchial epithelium as a key regulator of airway allergens sensitization and remodeling in asthma. Am J Respir Crit Care Med 2000;162:S113–S117.
Jenkins HA, Cool C, Szefler SJ, Covar R, Brugman S, Gelfand EW, et al. Histopathology of severe childhood asthma: a case series. Chest 2003;124:32–41.
Cutz E, Levison H, Cooper DM. DMltrastructure of airways in children with asthma. Histopathology 1978;2(6):407–421.
Park JW, Hong YK, Kim CW, Kim DK, Choe KO, Hong CS. CSigh- resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions, and bronchial hyperresponsiveness. J Invest Allergy Clin Immunol 1997;7: 186–192.
Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Tarked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992;101:916–921.
Huber HL, Koessler KK. KKhe pathology of bronchial asthma. Arch Intern Med 1922;30:689–760.
Hirst SJ, Martin JG, Bonacci JV, Chan V, Fixman ED, Hamid QA, et al. Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004;114:S2–S17.
Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Dirways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852–857.
Chu HW, Halliday JL, Martin RJ, Leung DY, Szefler SJ, Wenzel SE. SEollagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 1998;158:1936–1944.
Cokugras H, Akcakaya N, Seckin I, Camcioglu Y, Sarimurat N, Aksoy F. Fltrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax 2001;56:25–29.
Montefort S, Roche WR, Holgate ST. STronchial epithelial shedding in asthmatics and non-asthmatics. Respir Med 1993;87:9–11.
Lackie PM, Baker JE, Gunthert U, Holgate ST. STxpression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects. Am J Respir Cell Mol Biol 1997;16:14–22.
Puddicombe SM, Polosa R, Richter A, Krishna MT, Howart PH, Holgate ST, et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000;14:1362–1374.
Openshaw PJ, Turner-Warwick M. Observations on sputum production in patients with variable airflow obstruction: implications for the diagnosis of asthma and chronic bronchitis. Respir Med 1989; 83:25–31.
Houston JC, De Navasquez S, Trounce JR. JR clinical and pathologic study of fatal cases of status asthmaticus. Thorax 1953;8:207–213.
Dunnil MS. MShe pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960;13:27–33.
Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Knduction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin-4 in cell recruitment but not mucus production. J Exp Med 1997;186:1737–1747.
Society ATSER. ATSERespiratory mechanics in infants: physiologic evaluation in health and disease. Am Rev Respir Dis 1993;147:474–496.
Ducharme FM, Davis GM. GMeasurement of respiratory resistance in the emergency department: feasibility in young children with acute asthma. Chest 1997;111:1519–1525.
Enright PL, Lebowitz MD, Cockroft D. Dhysiologic measures: pulmonary function tests. Asthma outcome. Am J Respir Crit Care Med 1994;149:S9–S18.
Peress L, Sybrecht G, Macklem PT. PThe mechanism of increase in total lung capacity during acute asthma. Am J Med 1976;61:165–169.
Cormier Y, Lecours R, Legris C. Cechanisms of hyperinflation in asthma. Eur Respir J 1990;3:619–624.
Woolcock AJ, Read J. Jung volumes in exacerbations of asthma. Am J Med 1966;41:259–273.
Holmes PW, Campbell AH, Barter CE. CEcute changes of lung volumes and lung mechanics in asthma and in normal subjects. Thorax 1978;33:394–400.
Pellegrino R, Brusasco V. Vn the causes of lung hyperinflation during bronchoconstriction. Eur Respir J 1997;10:468–475.
Martin J, Powell E, Shore S, Emrich J, Engel LA. LAhe role of respiratory muscles in the hyperinflation of bronchial asthma. Am Rev Respir Dis 1980;121:441–447.
Wheatley JR, West S, Cala SJ, Engel LA. LAhe effect of hyperinflation on respiratory muscle work in acute induced asthma. Eur Respir J 1990;3:625–632.
Collett PW, Engel LA. LAnfluence of lung volume on oxygen cost of resistive breathing. J Appl Physiol 1986;61:16–24.
Weiner P, Suo J, Fernandez E, Cherniack RM. RMhe effect of hyperinflation on respiratory muscle strength and efficiency in healthy subjects and patients with asthma. Am Rev Respir Dis 1990;141: 1501–1505.
Aldrich TK, Hendler JM, Vizioli LD, Park M, Multz AS, Shapiro SM. SMntrinsic positive end-expiratory pressure in ambulatory patients with airways obstruction. Am Rev Respir Dis 1993;147:845–849.
Bohn D, Kissoon N. Ncute asthma. Pediatr Crit Care Med 2001; 2:151–163.
Wade OL, Gilson JC. JCffect of posture on diaphragmatic movement and vital capacity in normal subjects. Thorax 1951;6:103–126.
Frey B, Freezer N. Niagnostic value and pathophysiologic basis of pulsus paradoxus in infants and children with respiratory disease. Pediatr Pulmonol 2001;31:138–143.
Frey B, Butt W. Wulse oximetry for assessment of pulsus paradoxus: a clinical study in children. Intensive Care Med 1999;24:242–246.
Hartert TV, Wheeler AP, Sheller JR. JRse of pulse oximetry to recognize severity of airflow obstruction in obstructive airway disease: Correlation with pulsus paradoxus. Chest 1999;115:475–481.
Jay GD, Onuma K, Davis R, Chen M-H, Mansell A, Steele D. Dnalysis of physician ability in the measurement of pulsus paradoxus by sphygmomanometry. Chest 2000;118:348–352.
Rayner JR, Steele DW, Ziad A, Shaikhouni A, Jay GD. GDontinuous and non-invasive pulsus paradoxus monitoring. Acad Emerg Med 2003; 10:566–567.
Cook T, Stone G. Gediatric asthma: A correlation of clinical treatment and oxygen saturation. Hawaii Med J 1995;54:665–668.
Carruthers DM, Harrison BD. BDrterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax 1995;50:186–188.
McFadden ER, Lyons HA. HArterial blood gas tensions in asthma. N Engl J Med 1968;278:1027–1032.
Kerem E, Canny G, Tibshirani R, Reisman J, Bentur L, Schuh S, et al. Clinical–physiologic correlations in acute asthma of childhood. Pediatrics 1991;87:481–486.
Sole D, Komatsu MK, Carvalho KV, Naspitz CK. CKulse oximetry in the evaluation of the severity of acute asthma and/or wheezing in children. J Asthma 1999;36:327–333.
Yamamoto LG, Wiebe RA, Rosen LM, Ringwood JW, Uechi CM, Miller NC, et al. Oxygen saturation changes during the pediatric emergency department treatment of wheezing. Am J Emerg Med 1992;10:274–284.
Geelhoed GC, Landau LI, LeSouëf PN. Evaluation of SaO2 as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med 1994;23:1236–1241.
Cook T, Stone G. Gediatric asthma—a correlation of clinical treatment and oxygen saturation. Hawaii Med J 1995;54:665–668.
Morray B, Redding G. Gactors associated with prolonged hospitalization of children with asthma. Arch Pediatr Adolesc Med 1995;149: 276–279.
Hilliard TN, Witten H, Male IA, Hewer SL, Seddon PC. PCanagement of acute childhood asthma: a prospective multicentre study. Eur Respir J 2000;15:1102–1105.
Keogh KA, Macarthur C, Parkin PC, Stephens D, Arseneault R, Tennis O, et al. Predictors of hospitalization in children with acute asthma. J Pediatr 2001;139:273–277.
Keahey L, Bulloch B, Becker AB, Pollack CV Jr, Clark S, Camargo CA Jr. Initial oxygen saturation as a predictor of admission in children presenting to the emergency department with acute asthma. Ann Emerg Med 2002;40:300–307.
Hori T. Tathophysiological analysis of hypoxaemia during severe acute asthma. Arch Dis Child 1985;60:640–643.
Simpson H, Forfar JO, Grubb DJ. DJrterial blood gas tensions and pH in acute asthma in childhood. BMJ 1968;3:460–464.
Downes JJ, Wood DW, Striker TW, Pittman JC. JCrterial blood gas and acid–base disorders in infants and children with status asthmaticus. Pediatrics 1968;42(2):238–249.
Weng TR, Langer HM, Featherby EA, Levison H. Hrterial blood gas tensions and acid–base balance in symptomatic and asymptomatic asthma in childhood. Am Rev Respir Dis 1970;101:274–282.
Rodriguez-Roisin R. Gas exchange abnormalities in asthma. Lung 1990;168(Suppl):599–605.
Tsai S-L, Crain EF, Silver EJ, Goldman HS. HShat can we learn from chest radiographs in hypoxemic asthmatics? Pediatr Radiol 2002;32: 498–504.
National Heart Lung and Blood Institute: National Asthma Education Program. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: U.S. Department of Health and Human Services; 1997.
National Heart Lung and Blood Institute: National Asthma Education Program. National Asthma Education Program Expert Panel Report. Executive Summary: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: U.S. Department of Health and Human Services; 1991.
Gorelick MH, Stevens MW, Schultz T, Scribano PV. PVifficulty in obtaining peak expiratory flow measurements in children with acute asthma. Pediatr Emerg Care 2004;20:22–26.
Becker AB, Nelson NA, Simons FER. FERhe pulmonary index: assessment of a clinical score for asthma. Am J Dis Child 1984;138:574–576.
DiGuilio GA, Kercsmar CM, Krug SE, Alpert SE, Marx CM. CMospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. J Pediatr 1993;122:464–469.
Obata T, Kimura Y, Iikura Y. Yelationship between arterial blood gas tensions and a clinical score in asthmatic children. Ann Allergy 1992;68:530–532.
Roncoroni AJ, Adrougue HJ, De Obrutsky CW, Marchisio ML, Herrera MR. MRetabolic acidosis in status asthmaticus. Respiration 1976; 33(2):85–94.
Appel D, Rubenstein R, Schrager K, Williams MH, Jr. Lactic acidosis in severe asthma. Am J Med 1983;75:580–584.
Mountain RD, Heffner JE, Brackett NC, Jr, Sahn SA. Acid–base disturbances in acute asthma. Chest 1990;98:651–655.
Assadi FK. FKherapy of acute bronchospasm. Complicated by lactic acidosis and hypokalemia. Clin Pediatr (Phila) 1989;28(6):258–260.
Braden GL, Johnston SS, Germain MJ, Fitzgibbons JP, Dawson JA. JAactic acidosis associated with the therapy of acute bronchospasm. N Engl J Med 1985;313:890–891.
Rabbat A, Laaban JP, Boussairi A, Rochemaure J. Jyperlactatemia during acute severe asthma. Intensive Care Med 1998;24:85–94.
Yousef E, McGeady SJ. SJactic acidosis and status asthmaticus: how common in pediatrics? Ann Allergy Asthma Immunol 2002;89(6):585–588.
Manthous CA. CAactic acidosis in status asthmaticus: three cases and review of the literature. Chest 2001;119:1599–1602.
Okrent DG, Tessler S, Twersky RA, Tashkin DP. DPetabolic acidosis not due to lactic acidosis in patients with severe acute asthma. Crit Care Med 1987;15:1098–1101.
DaCruz D, Holburn C. Cerum potassium responses to nebulized salbutamol administered during an acute asthmatic attack. Arch Emerg Med 1989;6(1):22–26.
Du Plooy WJ, Hay L, Kahler CP, Schutte PJ, Brandt HD. HDhe dose-related hyper- and hypokalaemic effects of salbutamol and its arrhythmogenic potential. Br J Pharmacol 1994;111(1):73–76.
Haalboom JR, Deenstra M, Struyvenberg A. Aypokalaemia induced by inhalation of fenoterol. Lancet 1985;1(8438):1125–1127.
Haddad S, Arabi Y, Shimemeri AA. AAypokalemic paralysis mimicking Guillain-Barré syndrome and causing acute respiratory failure. Middle East J Anesthesiol 2004;17(5):891–897.
Haffner CA, Kendall MJ. MJetabolic effects of beta 2-agonists. J Clin Pharm Ther 1992;17(3):155–164.
Hung CH, Hua YM, Lee MY, Tsai YG, Yang KD. KDvaluation of different nebulized bronchodilators on clinical efficacy and hypokalemia in asthmatic children. Acta Paediatr Taiwan 2001;42(5):287–290.
Kolski GB, Cunningham AS, Niemec PW Jr, Davignon GF Jr, Freehafer JG. Hypokalemia and respiratory arrest in an infant with status asthmaticus. J Pediatr 1988;112:304–307.
Singhi S, Marudkar A. Aypokalemia in a pediatric intensive care unit. Indian Pediatr 1996;33(1):9–14.
Singhi SC, Jayashree K, Sarkar B. Bypokalaemia following nebulized salbutamol in children with acute attack of bronchial asthma. J Paediatr Child Health 1996;32(6):495–497.
Smith SR, Kendall MJ. MJotentiation of the adverse effects of intravenous terbutaline by oral theophylline. Br J Clin Pharmacol 1986; 21(4):451–453.
Tsai WS, Wu CP, Hsu YJ, Lin SH. SHife-threatening hypokalemia in an asthmatic patient treated with high-dose hydrocortisone. Am J Med Sci 2004;327:152–155.
Singleton R, Moel DI, Cohn RA. RAreliminary observation of impaired water excretion in treated status asthmaticus. Am J Dis Child 1986; 140(1):59–61.
Iikura Y, Odajima Y, Akazawa A, Nagakura T, Kishida M, Akimoto K. Kntidiuretic hormone in acute asthma in children: effects of medication on serum levels and clinical course. Allergy Proc 1989;10(3):197–201.
Stalcup SA, Mellins RB. RBechanical forces producing pulmonary edema in acute asthma. N Engl J Med 1977;297:592–596.
Brooks LJ, Cloutier MM, Afshani E. Eignificance of roentgenographic abnormalities in children hospitalized for asthma. Chest 1982;82: 315–318.
Alario AJ, McCarthy PL, Markovitz R, Kornguth P, Rosenfield N, Leventhal JM. JMsefulness of chest radiographs in children with acute lower respiratory tract disease. J Pediatr 1987;111(2):187–193.
Gay BB Jr. Radiologic evaluation of the nontraumatized child with respiratory distress. Radiol Clin North Am 1978;16(1):91–112.
Gershel JC, Goldman HS, Stein RE, Shelov SP, Ziprkowski M. Mhe usefulness of chest radiographs in first asthma attacks. N Engl J Med 1983;309:336–339.
Ismail Y, Loo CS, Zahary MK. MKhe value of routine chest radiographs in acute asthma admissions. Singapore Med J 1994;35(2):171–172.
Kita Y, Sahara H, Yoshita Y, Shibata K, Ishise J, Kobayashi T. Ttatus asthmaticus complicated by atelectasis in a child. Am J Emerg Med 1995;13(2):164–167.
Mahabee-Gittens EM, Bachman DT, Shapiro ED, Dowd MD. MDhest radiographs in the pediatric emergency department for children ? or =18 months of age with wheezing. Clin Pediatr (Phila) 1999;38(7):395–399.
Press S, Lipkind RS. RS treatment protocol of the acute asthma patient in a pediatric emergency department. Clin Pediatr (Phila) 1991;30(10): 573–577.
Roback MG, Dreitlein DA. DAhest radiograph in the evaluation of first time wheezing episodes: review of current clinical practice and efficacy. Pediatr Emerg Care 1998;14(3):181–184.
Rushton AR. ARhe role of the chest radiograph in the management of childhood asthma. Clin Pediatr (Phila) 1982;21(6):325–328.
Zieverink SE, Harper AP, Holden RW, Klatte EC, Brittain H. Hmergency room radiography of asthma: an efficacy study. Radiology 1982;145(1):27–29.
Spottswood SE, Allison KZ, Lopatina OA, Sethi NN, Narla LD, Lowry PA, et al. The clinical significance of lung hypoexpansion in acute childhood asthma. Pediatr Radiol 2004;34(4):322–325.
Kelly CS, Andersen CL, Pestian JP, Wenger AD, Finch AB, Strope GL, et al. Improved outcomes for hospitalized asthmatic children using a clinical pathway. Ann Allergy Asthma Immunol 2000;84(5):509–516.
McDowell KM, Chatburn RL, Myers TR, O’Riordan MA, Kercsmar CM. CM cost-saving algorithm for children hospitalized for status asthmaticus. Arch Pediatr Adolesc Med 1998;152(10):977–984.
Wazeka A, Valacer DJ, Cooper M, Caplan DW, DiMaio M. Mmpact of a pediatric asthma clinical pathway on hospital cost and length of stay. Pediatr Pulmonol 2001;32:211–216.
Kwan-Gett TS, Lozano P, Mullin K, Marcuse EK. EKne-year experience with an inpatient asthma clinical pathway. Arch Pediatr Adolesc Med 1997;151:684–689.
Chien JW, Ciufo R, Novak R, Skowronski M, Nelson J, Coreno A, et al. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000;117:728–733.
Tal A, Pasterkamp H, Leahy F. Frterial oxygen desaturation following salbutamol inhalation in acute asthma. Chest 1984;86:868–869.
Douglas JG, Rafferty P, Fergusson RJ. RJebulised salbutamol without oxygen in severe acute asthma: How effective and how safe? Thorax 1985;40:180–183.
Connett G, Lenney W. Wrolonged hypoxaemia after nebulised salbutamol. Thorax 1993;48:574–575.
Gleeson JG, Green S, Price JF. JFir or oxygen as driving gas for nebulized salbutamol. Arch Dis Child 1988;63:900–904.
Collins JV, Jones D. Dorticosteroids in the treatment of severe acute asthma (status asthmaticus). Acta Tuberc Pneumol Belg 1977; 68(1):63–73.
Harfi H, Hanissian AS, Crawford LV. LVreatment of status asthmaticus in children with high doses and conventional doses of methylprednisolone. Pediatrics 1978;61(6):829–831.
Pierson WE, Bierman CW, Kelley VC. VC double-blind trial of corticosteroid therapy in status asthmaticus. Pediatrics 1974;54(3):282–288.
Younger RE, Gerber PS, Herrod HG, Cohen RM, Crawford LV. LVntravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics 1987;80(2):225–230.
Tal A, Levy N, Bierman JE. JEethylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics 1990;86:350–356.
Shapiro GG, Furukawa CT, Pierson WE, Gardinier R, Bierman CW. CWouble-blind evaluation of methylprednisolone versus placebo for acute asthma episodes. Pediatrics 1983;71:510–514.
Rowe BH, Keller JL, Oxman AD. ADffectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med 1992;10:301–310.
Scarfone RJ, Fuchs SM, Nager AL, Shane SA. SAontrolled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993;92:513–518.
Kattan M, Gurwitz D, Levison H. Horticosteroids in status asthmaticus. J Pediatr 1980;96(3?Pt 2):596–599.
Smith M, Iqbal S, Elliot TM, Everard M, Rowe BH. BHorticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2003;CD002886.
Collins JV, Clark TJ, Harris PW, Townsend J. Jntravenous corticosteroids in treatment of acute bronchial asthma. Lancet 1970;21:1047–1049.
Langton Hewer S, Hobbs J, Reid F, Lenney W. Wrednisolone in acute childhood asthma: clinical response to three dosages. Respir Med 1998;92:541–546.
Raimondi AC, Figueroa-Casa JC, Roncoroni AJ. AJomparison between high and moderate doses of hydrocortisone in the treatment of status asthmaticus. Chest 1986;89:832–835.
Britton MG, Collins JV, Brown D, Fairhurst NP, Lambert RG. RGigh-dose corticosteroids in severe acute asthma. BMJ 1976;2:73–74.
Emerman CL, Cydulka RK. RK randomized comparison of 100-mg vs 500-mg dose of methylprednisolone in the treatment of acute asthma. Chest 1995;107:1559–1563.
Marquette CH, Stach B, Cardot E, Bervar JF, Saulnier F, Lafitte JJ, et al. High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur Respir J 1995;8:22–27.
Matthews EE, Curtis PD, McLain BI, Morris LS, Turbitt ML. MLebulized budesonide versus oral steroid in severe exacerbations of childhood asthma. Acta Paediatr 1999;88:841–843.
Devidayal, Singhi S, Kumar L, Jayshree M. Mfficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999;88:835–840.
Scarfone RJ, Loiselle JM, Wiley JF, II, Decker JM, Henretig FM, Joffe MD. MDebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann Emerg Med 1995;26: 480–486.
Schuh S, Reisman J, Alshehri M, Dupuis A, Corey M, Arseneault R, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000;343:689–694.
Becker JM, Arora A, Scarfone RJ, Spector ND, Fontana-Penn ME, Gracely E, et al. Oral versus intravenous corticosteroids in children hospitalized with asthma. J Allergy Clin Immunol 1999;103:586–590.
Barnett PJ, Caputo GL, Baskin M, Kupperman N. Nntravenous versus oral corticosteroids in the management of acute asthma in children. Ann Emerg Med 1997;29:212–217.
Klig JE, Hodge D, III, Rutherford MW. MWymptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. J Asthma 1997;34:419–425.
Klaustermeyer WB, Hale FC. FChe physiologic effect of an intravenous glucocorticoid in bronchial asthma. Ann Allergy 1976;37:80–86.
Wolfson DH, Nypaver MM, Blaser M, Hogan A, Evans RI, Davis AT. AT controlled trial of methylprednisolone in the early emergency department treatment of acute asthma in children. Pediatr Emerg Care 1994;10:335–338.
Rodrigo C, Rodrigo G. Garly administration of hydrocortisone in the emergency room treatment of acute asthma: a controlled clinical trial. Respir Med 1994;88:755–761.
Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. GWarly emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001;1:CD002178.
Blackwell TS, Christman JW. JWhe role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Crit Care Med 1997;17:3–9.
Barnes PJ, Karin M. Muclear factor-kappa B—a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066–1071.
Hayashi R, Wada H, Ito K, Adcock IM. IMffects of glucocorticoids on gene transcription. Eur J Pharmacol 2004;500:51–62.
Barnes PJ, Adcock IM. IMow do corticosteroids work in asthma? Ann Intern Med 2003;139:359–370.
Schramm CM. CMeta-adrenergic relaxation of rabbit tracheal smooth muscle: a receptor deficit that improves with corticosteroid administration. J Pharmacol Exp Ther 2000;292:280–287.
Kalavantavanich K, Schramm CM. CMexamethasone potentiates high-affinity beta-agonist binding and g(s) alpha protein expression in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2000;278:L1101–L1106.
Rodrigo C, Rodrigo G. Gorticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest 1999;116:285–295.
Liu L, Wang YX, Zhou J, Long F, Sun HW, Liu Y, et al. Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm Res 2005;54:37–41.
Pitzalis C, Pipitone N, Perretti M. Megulation of leukocyte–endothelial interactions by glucocorticoids. Ann NY Acad Sci 2002;966: 108–118.
Croxtall JD, van Hal PT, Choudhury Q, Gilroy DW, Flower RJ. RJifferent glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br J Pharmacol 2002;135:511–519.
Townley RG, Suliaman F. Fhe mechanism of corticosteroids in treating asthma. Ann Allergy 1987;58:1–6.
Rodrigo G, Rodrigo C. Cnhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998;157:698–703.
Rodrigo GJ. GJomparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med 2005;171:1231–1236.
Siegel SC, Richards W. Wtatus asthmaticus in children. Int Anesthesiol Clin 1971;9(1):99–115.
Bocles JS. JStatus asthmaticus. Med Clin North Am 1970;54(2):493–509.
Kampschulte S, Marcy J, Safar P. Pimplified physiologic management of status asthmaticus in children. Crit Care Med 1973;1(2):69–74.
Becker AB, Nelson NA, Simons FE. FEnhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children. J Pediatr 1983;102:465–469.
Simons FE, Gillies JD. JDose response of subcutaneous terbutaline and epinephrine in children with acute asthma. Am J Dis Child 1981; 135:214–217.
Tinkelman DG, Vanderpool GE, Carroll MS, Lotner GZ, Spangler DL. DLomparison of nebulized terbutaline and subcutaneous epinephrine in the treatment of acute asthma. Ann Allergy 1983;50:398–401.
Uden DL, Goetz DR, Kohen DP, Fifield GC. GComparison of nebulized terbutaline and subcutaneous epinephrine in the treatment of acute asthma. Ann Emerg Med 1985;14:229–232.
Victoria MS, Battista CJ, Nangia BS. BSomparison between epinephrine and terbutaline injections in the acute management of asthma. J Asthma 1989;26:287–290.
Appel D, Karpel JP, Sherman M. Mpinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate. J Allergy Clin Immunol 1989;84:90–98.
Kornberg AE, Zuckerman S, Welliver JR, Mezzadri F, Aquino N. Nffect of injected long-acting epinephrine in addition to aerosolized albuterol in the treatment of acute asthma in children. Pediatr Emerg Care 1991;7:1–3.
Lin YZ, Hsieh KH, Chang LF, Chu CY. CYerbutaline nebulization and epinephrine injection in treating acute asthmatic children. Pediatr Allergy Immunol 1996;7:95–99.
Safdar B, Cone DC, Pham KT. KTubcutaneous epinephrine in the prehospital setting. Prehosp Emerg Care 2001;5:200–207.
Sharma A, Madan A. Aubcutaneous epinephrine vs nebulized salbutamol in asthma. Indian J Pediatr 2001;68:1127–1130.
Amory DW, Burnham SC, Cheney FW. FWomparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutaline in patients with reversible airway obstruction. Chest 1975;67:279–286.
Schwartz AL, Lipton JM, Warburton D, Johnson LB, Twarog FJ. FJanagement of acute asthma in childhood. A randomized evaluation of beta-adrenergic agents. Am J Dis Child 1980;134:474–478.
Ben-Zvi Z, Lam C, Hoffman J, Teets-Grimm K, Kattan M. Mn evaluation of the initial treatment of acute asthma. Pediatrics 1982;70: 348–353.
Becker AB, Nelson NA, Simons FER. FERnhaled salbutamol vs injected epinephrine in the treatment of acute asthma in children. J Pediatr 1983;102:465–469.
Littner MR, Tashkin DP, Siegel SC, Katz R. Rouble-blind comparison of acute effects of inhaled albuterol, isoproterenol, and placebo on cardiopulmonary function and gas exchange in asthmatic children. Ann Allergy 1983;50:309–316.
Oberklaid F, Mellis CM, Souef PN, Geelhoed GC, Maccarrone AL. AL comparison of a bodyweight dose versus a fixed dose of nebulised salbutamol in acute asthma in children. Med J Aust 1993;158:751–753.
Schuh S, Parkin P, Rajan A, Canny G, Healy R, Rieder M, et al. High- versus low-dose frequently administered nebulised albuterol in children with severe acute asthma. Pediatrics 1989;83:513–518.
Schuh S, Reider MJ, Canny G, Pender E, Forbes T, Tan YK, et al. Nebulised albuterol in acute childhood asthma: comparison of two doses. Pediatrics 1990;86:509–513.
Reilly PA, Yahav J, Mindorff C, Kazim F, Levison H. Hose response characteristics of nebulized fenoterol in asthmatic children. J Pediatr 1983;103:121–126.
Heimer D, Shim C, Williams MH Jr. The effect of sequential inhalations of metaproterenol aerosol in asthma. J Allergy Clin Immunol 1980;66:75–77.
Robertson CF, Smith F, Beck R, Levison H. Hesponse to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr 1985;106: 672–674.
Penna AC, Dawson KP. KPebulised salbutamol; systemic absorption could be important in achieving bronchodilation. J Asthma 1993;30: 105–107.
Penna AC, Dawson KP, Manglick P. Pxtremely high plasma salbutamol concentrations in three children treated for acute asthma. Aust J Hosp Pharm 1993;23:165–167.
Penna AC, Dawson KP, Manglick P, Tam J. Jystemic absorption following nebuliser delivery in acute asthma. Acta Paediatr 1993;82: 963–966.
Amirav I, Newhouse MT. MTetered-dose inhaler accessory devices in acute asthma. Arch Pediatr Adolesc Med 1997;151:876–882.
Rubilar L, Castro-Rodriguez JA, Girardi G. Gandomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol 2000;29:264–269.
Clay MM, Pavia D, Newman SP, Lennard-Jones T, Clarke SW. SWssessment of jet nebulisers for lung aerosol therapy. Lancet 1983;2:592–594.
Hess D, Horney D, Snyder T. Tedication-delivery performance of eight small-volume, hand-held nebulizers: Effects of diluent volume, gas, flow rate, and nebulizer model. Respir Care 1989;34:717–723.
Scarfone RJ, Friedlaender EY. EYeta-2-agonists in acute asthma: the evolving state of the art. Pediatr Emerg Care 2002;18:442–447.
Ba M, Thivierge RL, Lapierre JG, Gaudreault P, Spier S, Lamarre A. Affects of continuous inhalation of salbutamol in acute asthma [abstr]. Am Rev Respir Dis 1987;135:A326.
Salazar RO, Joos TH, Nickles PA, Pierantoni WN. WNreatment of status asthmaticus with continuous nebulized albuterol therapy in children [abstr]. J Allergy Clin Immunol 1990;85:A210.
Katz RW, Kelly HW, Crowley MR, Grad R, McWilliams BC, Murphy SJ. SJafety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics 1993;92:666–669.
Papo MC, Frank J, Thompson AE. AE prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21(10):1479–1486.
Singh M, Kumar L. Lontinuous nebulised salbutamol and oral once a day prednisolone in status asthmaticus. Arch Dis Child 1993; 69(4):416–419.
Craig VL, Bigos D, Brilli RJ. RJfficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus. Pediatr Emerg Care 1996;12(1):1–5.
Montgomery VL, Eid NS. NSow-dose beta-agonist continuous nebulization therapy for status asthmaticus in children. J Asthma 1994; 31(3):201–207.
Siegel AJ, Silverman LM, Holman BL. BLlevated creatine kinase isoenzyme level in marathon runners. Normal myocardial scintigrams suggest noncardiac source. JAMA 1981;246:2049–2051.
Siegel AJ, Silverman LM, Lopez RE. REreatine kinase elevations in marathon runners: relationship to training and competition. Yale J Biol Med 1980;53:275–279.
Jaffe AS, Garfinkel BT, Ritter CS, Sobel BE. BElasma MB creatine kinase after vigorous exercise in professional athletes. Am J Cardiol 1984;53: 856–858.
Choi YS. YSerum enzyme monitoring in asthma patients [letter]. Pediatrics 1992;90:279–280.
Adcock IM, Peters MJ, Brown CR, Stevens DA, Barnes PJ. PJigh concentrations of beta-adrenergic agonists inhibit DNA binding of glucocorticoids in human lungs in vitro. Biochem Soc Trans 1995;23:217S.
Peters MJ, Adcock IM, Brown CR, Barnes PJ. β-Agonist inhibition of steroid receptor DNA binding activity in human lung [abstr]. Am Rev Respir Dis 1993;147:A772.
Peters MJ, Adcock IM, Brown CR, Barnes PJ. PJeta-adrenoreceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 1995;289:275–281.
Pang LM, Rodriguez-Martinez F, Davis WJ, Mellins RB. RBerbutaline in the treatment of status asthmaticus. Chest 1977;72(4):469–473.
Moler FW, Hurwitz ME, Custer JR. JRmprovement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988;81: 1101–1109.
Moler FW, Johnson CE, Van Laanen C, Palmisano JM, Nasr SZ, Akingbola O. Oontinuous versus nebulized terbutaline: plasma levels and effects. Am J Respir Crit Care Med 1995;151:602–606.
Portnoy J, Aggarwal J. Jontinuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children. Ann Allergy 1988;60:368–371.
Hultquist C, Lindberg C, Nyberg B, Kjellman B, Wettrell G. Ginetics of terbutaline in asthmatic children. Eur J Respir Dis Suppl 1984; 134:195–203.
Tipton WR, Nelson HS. HSrequent parenteral terbutaline in the treatment of status asthmaticus in children. Ann Allergy 1987;58(4):252–256.
Stephanopoulos DE, Monge R, Schell KH, Wyckoff P, Peterson BM. BMontinuous intravenous terbutaline for pediatric status asthmaticus. Crit Care Med 1998;26(10):1744–1748.
Fuglsang G, Pedersen S, Borgstrom L. Lose–response relationships of intravenously administered terbutaline in children with asthma. J Pediatr 1989;114:315–320.
Hultquist C, Lindberg C, Nyberg L, Kjellman B, Wettrell G. Gharmacokinetics of intravenous terbutaline in asthmatic children. Dev Pharmacol Ther 1989;13:11–20.
O’Connell MB, Iber C. Continuous intravenous terbutaline infusions for adult patients with status asthmaticus. Ann Allergy 1990;64:213–219.
Pierce RJ, Payne CR, Williams SJ, Denison DM, Clark TJ. TJomparison of intravenous and inhaled terbutaline in the treatment of asthma. Chest 1981;79:506–511.
Williams SJ, Winner SJ, Clark TJ. TJomparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax 1981;36:629–632.
Van Renterghem D, Lamont H, Elinck W, Pauwels R, Van Der Straeten M. Intravenous versus nebulized terbutaline in patients with acute severe asthma; a double-blind randomized study. Ann Allergy 1987;59:313–316.
Chiang VW, Burns JP, Rifai N, Lipshultz SE, Adams MJ, Weiner DL. DLardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr 2000;137: 73–77.
Hardasmalani MD, DeBari V, Bithoney WG, Gold N. Nevalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care 2005;21:415–419.
Ralston ME, Euwema MS, Knecht KR, Ziolkowski TJ, Coakley TA, Cline SM. SMomparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized, controlled trial. J Emerg Med 2005;29:29–35.
Qureshi F, Zaritsky A, Welch C, Meadows T, Burke BL. BLlinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med 2005;46:29–36.
Carl JC, Myers TR, Kirchner HL, Kercsmar CM. CMomparison of racemic albuterol and levalbuterol for treatment of acute asthma. J Pediatr 2003;143:731–736.
Steiner P, Rao M, Ehrlich R, Padre R. Rhe use of intravenous isoproterenol in the treatment of status asthmaticus. J Asthma Res 1975;12(4):215–219.
Herman JJ, Noah ZL, Moody RR. RRse of intravenous isoproterenol for status asthmaticus in children. Crit Care Med 1983;11(9):716–720.
Parry WH, Martorano F, Cotton EK. EKanagement of life-threatening asthma with intravenous isoproterenol infusions. Am J Dis Child 1976;130(1):39–42.
Victoria MS, Tayaba RG, Nangia BS. BSsoproterenol infusion in the management of respiratory failure in children with status asthmaticus: experience in a small community hospital and review of the literature. J Asthma 1991;28(2):103–108.
Newman LJ, Richards W, Church JA. JAsoetharine-isoproterenol: a comparison of effects in childhood status asthmaticus. Ann Allergy 1982;48(4):230232.
Downes JJ, Wood DW, Harwood I, Sheinkopf HN, Raphaely RC. RCntravenous isoproterenol infusion in children with severe hypercapnia due to status asthmaticus. Effects on ventilation, circulation, and clinical score. Crit Care Med 1973;1(2):63–68.
Phanichyakarn P, Pongpanich B, Ayudthya PS, Vongpraomas C, Krisarin C, Vongvivat K, et al. Intravenous isoproterenol infusion in asthmatic attacks and life threatening status asthmaticus in Thai children. J Med Assoc Thai 1978;61(9):529–535.
Wood DW, Downes JJ. JJntravenous isoproterenol in the treatment of respiratory failure in childhood status asthmaticus. Ann Allergy 1973;31(12):607–610.
Maguire JF, Geha RS, Umetsu DT. DTyocardial specific creatine phosphokinase isoenzyme elevation in children with asthma treated with intravenous isoproterenol. J Allergy Clin Immunol 1986;78(4?Pt 1): 631–636.
Mikhail MS, Hunsinger SY, Goodwin SR, Loughlin GM. GMyocardial ischemia complicating therapy of status asthmaticus. Clin Pediatr (Phila) 1987;26(8):419–421.
Maguire JF, O’Rourke PP, Colan SD, Geha RS, Crone R. Rardiotoxicity during treatment of severe childhood asthma. Pediatrics 1991; 88(6):1180–1186.
Matson JR, Loughlin GM, Strunk RC. RCyocardial ischemia complicating the use of isoproterenol in asthmatic children. J Pediatr 1978; 92:776–778.
Bohn D, Kalloghlian A, Jenkins J, Edmonds J, Barker G. Gntravenous salbutamol in the treatment of status asthmaticus in children. Crit Care Med 1984;12(10):892–896.
Browne GJ, Penna AC, Phung X, Soo M. Mandomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997;349:301–305.
Browne GJ, Lam LT. LTingle-dose intravenous salbutamol bolus for managing children with acute severe asthma in the emergency department: reanalysis of data. Pediatr Crit Care Med 2002;3:117–123.
Sellers WF, Messahel B. Bapidly repeated intravenous boluses of salbutamol for acute severe asthma. Anaesthesia 2003;58:680–683.
Roberts G, Newsom D, Gomez K, Raffles A, Saglani S, Begent J, et al. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax 2003;58:306–310.
Browne GJ, Trieu L, Van Asperen P. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department. Crit Care Med 2002;30:448–453.
Habashy D, Lam LT, Browne GJ. GJhe administration of beta2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: a cross-sectional survey. Eur J Emerg Med 2003;10(3):219–224.
Rodrigo GJ, Rodrigo C. Che role of anticholinergics in acute asthma treatment: an evidence-based evaluation. Chest 2002;121:1977–1987.
Barnes PJ, Minette P, Maclagan J. Juscarinic receptor subtypes in the airways. Trends Pharmacol Sci 1988;9:412–416.
Barnes PJ. PJuscarinic receptor subtypes in airways. Life Sci 1993; 52:529–536.
Fryer AD, Jacoby DB. DBffect of inflammatory cell mediators on M2 muscarinic receptors in the lungs. Life Sci 1993;52:529–536.
Rowe BH, Travers AH, Holroyd BR, Kelly KD, Bota GW. GWebulized ipratropium bromide in acute pediatric asthma: does it reduce hospital admissions among children presenting to the emergency department? Ann Emerg Med 1999;34:75–85.
Aaron SD. SDhe use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review. J Asthma 2001;38:521–530.
Schuh S, Johnson DW, Callahan S, Canny G, Levison H. Hfficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr 1995;126:639–645.
Qureshi F, Pestian J, Davis P, Zaritsky A. Affect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998;339:1030–1035.
Zorc JJ, Pusic MV, Ogborn CJ, Lebet R, Duggan AK. AKpratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics 1999;103:748–752.
Goggin N, Macarthur C, Parkin PC. PCandomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med 2001;155:1329–1334.
Craven D, Kercsmar CM, Myers TR, O’Riordan MA, Golonka G, Moore S. Spratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. J Pediatr 2001;138(1):51–58.
Roselló HJ, Plá JC. Sulfato de magnesio en la crisis de asthma. Prensa Med Argent 1936;23:1677–1680.
Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T. Tronchodilating effects of intravenous magnesium sulfate in bronchial asthma. JAMA 1987;257:1076–1078.
Rolla G, Bucca C, Caria E, Arossa W, Bugiani M, Cesano L, et al. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. Ann Allergy 1988;61:388–391.
Noppen M, Vanmaele L, Impens N, Schandevyl W. Wronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 1990;97:373–376.
Dominguez LJ, Barbagallo M, Di Lorenzo G, Drago A, Scola S, Morici G, et al. Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clin Sci (Lond) 1998;95:137–142.
McNamara RM, Spivey WH, Skobeloff E, Jacubowitz S. Sntravenous magnesium sulfate in the management of acute respiratory failure complicating asthma. Ann Emerg Med 1989;18:197–199.
Kuitert LM, Kletchko SL. SLntravenous magnesium sulfate in acute, life-threatening asthma. Ann Emerg Med 1991;20:1243–1245.
Sydow M, Crozier TA, Zielmann S, Radke J, Burchardi H. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med 1993;19:467–471.
Kakish KS. KSerum magnesium levels in asthmatic children during and between exacerbations. Arch Pediatr Adolesc Med 2001;155(2):181–183.
Zervas E, Papatheodorou G, Psathakis K, Panagou P, Georgatou N, Loukides S. Seduced intracellular Mg concentrations in patients with acute asthma. Chest 2003;123:113–118.
Falkner D, Glauser J, Allen M. Merum magnesium levels in asthmatic patients during exacerbations of asthma. Am J Emerg Med 1992; 10:1–3.
Emelyanov A, Fedoseev G, Barnes PJ. PJeduced intracellular magnesium concentrations in asthmatic patients. Eur Respir J 1999;13: 38–40.
Hashimoto Y, Nishimura Y, Maeda H, Yokoyama M. Mssessment of magnesium status in patients with bronchial asthma. J Asthma 2000;37:489–496.
Bodenhamer J, Bergstrom R, Brown D, Gabow P, Marx JA, Lowenstein SR. SRrequently nebulized beta-agonists for asthma: effects on serum electrolytes. Ann Emerg Med 1992;21:1337–1342.
de Castillo J, Engbaek L. Lhe nature of the neuromuscular block produced by magnesium. J Physiol 1954;124:370–384.
Altura BM, Altura BT, Waldemar Y. Yrostaglandin-induced relaxations and contractions of arterial smooth muscle: effects of magnesium ions. Artery 1976;2:326–336.
Iseri LT, French JH. JHagnesium: Nature’s physiologic calcium blocker. Am Heart J 1984;108:188–193.
Brandt DR, Ross EM. EMatecholamine-stimulated GTPase cycle: multiple sites of regulation by beta-adrenergic receptor and Mg2+ studied in reconstituted receptor-Gs vesicles. J Biol Chem 1986;261:1656–1664.
Spivey WH, Skobeloff EM, Levin RM. RMffect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med 1990;19:1107–1112.
Ransnas LA, Jasper JR, Leiber D, Insel PA. PAeta-adrenergic-receptor-mediated dissociation and membrane release of the Gs protein in S49 lymphoma-cell membranes. Dependence on Mg2+ and GTP. Biochem J 1992;283:519–524.
Cairns CB, Kraft M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Acad Emerg Med 1996;3:1093–1097.
Mangat HS, D’Souza GA, Jacob MS. MSebulized magnesium sulfate versus nebulized salbutamol in acute bronchial asthma: a clinical trial. Eur Respir J 1998;12:341–344.
Nannini LJ Jr, Pendino JC, Corna RA, Mannarino S, Quispe R. Ragnesium sulfate as a vehicle for nebulized salbutamol in acute asthma. Am J Med 1998;108:193–197.
Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med 2000;36:181–190.
Rodrigo G, Rodrigo C, Burschtin O. Officacy of magnesium sulfate in acute adult asthma: a meta-analysis of randomized trials. Am J Emerg Med 2000;18:216–221.
Pabon H, Monem G, Kissoon N. Nafety and efficacy of magnesium sulfate infusions in children with status asthmaticus. Pediatr Emerg Care 1994;10(4):200–203.
Ciarallo L, Sauer AH, Shannon MW. MWntravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr 1996;129:809–814.
Devi PR, Kumar L, Singhi SC, Prasad R, Singh M. Mntravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. Indian Pediatr 1997;34:389–397.
Gurkan F, Haspolat K, Bosnak M, Dikici B, Derman O, Ece A. Antravenous magnesium sulfate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy. Eur J Emerg Med 1999;6:201–205.
Scarfone RJ, Loiselle JM, Joffe MD, Mull CC, Stiller S, Thompson K, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med 2000;36:572–578.
Ciarallo L, Broussea D, Reinert S. Sigher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 2000;154:979–983.
Markovitz B. Boes magnesium sulphate have a role in the management of paediatric status asthmaticus? Arch Dis Child 2002;86(5):381–382.
Cheuk DK, Chau TC, Lee SL. SL meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005;90: 74–77.
Skobeloff EM, Spivey WH, McNamara RM, Greenspon L. Lntravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 1989;262:1210–1213.
Skorodin MS, Freebeck PC, Yetter B, Nelson JE, Van de Graff WB, Walsh JM. JMagnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline. Chest 1994;105:701–705.
Pierson WE, Bierman CW, Stamm SJ, Van Arsdel PP Jr. Double-blind trial of aminophylline in status asthmaticus. Pediatrics 1971;48(4): 642–646.
Hambleton G, Stone MJ. MJomparison of IV salbutamol with IV aminophylline in the treatment of severe, acute asthma in childhood. Arch Dis Child 1979;54:391–402.
Carter E, Cruz M, Chesrown S, Shieh G, Reilly K, Hendeles L. Lfficacy of intravenously administered theophylline in children hospitalized with severe asthma. J Pediatr 1993;122:470–476.
Strauss RE, Wertheim DL, Bonagura VR, Valacer DJ. DJminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations. Pediatrics 1994;93:205–210.
Bien JP, Bloom MD, Evans RL, Specker B, O’Brien KP. Intravenous theophylline in pediatric status asthmaticus. A prospective, randomized, double-blind, placebo-controlled trial. Clin Pediatr (Phila) 1995;34(9):475–481.
Needleman JP, Kaifer MC, Nold JT, Shuster PE, Redding MM, Gladstein J. Jheophylline does not shorten hospital stay for children admitted for asthma. Arch Pediatr Adolesc Med 1995;149:206–209.
Nuhoglu Y, Dai A, Barlan IB, Basaran MM. MMfficacy of aminophylline in the treatment of acute asthma exacerbations in children. Ann Allergy Asthma Immunol 1998;80:395–398.
Goodman DC, Littenberg B, O’Connor GT, Brooks JG. JGheophylline in acute childhood asthma: a meta-analysis of its efficacy. Pediatr Pulmonol 1996;21:211–218.
Montserrat JM, Barbera JA, Viegas C, Roca J, Rodriguez-Roisin R. Gas exchange response to intravenous aminophylline in patients with a severe exacerbation of asthma. Eur Respir J 1995;8:28–33.
Wagner PD, Dantzker DR, Iacovoni VE, Tomlin WC, West JB. JBentilation–perfusion inequality in asymptomatic asthma. Am Rev Respir Dis 1978;118:511–524.
Ballester E, Reyes A, Roca J, Guitart R, Wagner PD, Rodriguez-Roisin R. Ventilation–perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 1989;44:258–267.
Bell M, Jackson E, Mi Z, McCombs J, Carcillo J. Jow-dose theophylline increases urine output in diuretic-dependent critically ill children. Intensive Care Med 1998;24:1099–1105.
Yung M, South M. Mandomized controlled trial of aminophylline for severe acute asthma. Arch Dis Child 1998;79:405–410.
Ream RS, Loftis LL, Albers GM, Becker BA, Lynch RE, Mink RB. RBfficacy of IV theophylline in children with severe status asthmaticus. Chest 2001;119(5):1480–1488.
Wheeler DS, Jacobs BR, Kenreigh CA, Bean JA, Hutson TK, Brilli RJ. RJheophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. Pediatr Crit Care Med 2005;6:142–147.
Ho AM-H, Lee A, Karmakar MK, Dion PW, Chung DC, Contardi LH. LHeliox vs air–oxygen mixtures for the treatment of patients with acute asthma: a systematic overview. Chest 2003;123:882–890.
Gupta VK, Cheifetz IM. IMeliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr Crit Care Med 2005;6:204–211.
Kudukis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME. MEnhaled helium–oxygen revisited: effect of inhaled helium–oxygen during the treatment of status asthmaticus in children. J Pediatr 1997;130(2):217–224.
Tobias JD, Garrett JS. JSherapeutic options for severe, refractory status asthmaticus: inhalational anaesthetic agents, extracorporeal membrane oxygenation and helium/oxygen ventilation. Paediatr Anaesth 1997;7(1):47–57.
Gluck EH, Onorato DJ, Castriotta R. Relium–oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990;98:693–698.
Haynes JM, Sargent RJ, Sweeney EL. ELse of heliox to avoid intubation in a child with acute severe asthma and hypercapnia. Am J Crit Care 2003;12:28–30.
Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM. RMelium–oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatr Crit Care Med 2003;4:353–357.
Schaeffer EM, Pohlman A, Morgan S, Hall JB. JBxygenation in status asthmaticus improves during ventilation with helium–oxygen. Crit Care Med 1999;27(12):2666–2670.
Carter ER, Webb CR, Moffitt DR. DRvaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial. Chest 1996;109:1256–1261.
Rodrigo GJ, Rodrigo C, Pollack CV, Rowe B. Bse of helium–oxygen mixtures in the treatment of acute asthma: a systematic review. Chest 2003;123(3):891–896.
Kim IK, Phrampus E, Venkataraman S, Pitteti R, Saville A, Corcoran T, et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005;116:1127–1133.
Huber FC Jr., Gutierrez J, Corssen G. Getamine: its effect on airway resistance in man. South Med J 1972;65(10):1176–1180.
Hirshman CA, Downes H, Farbood A, Bergman NA. NAetamine block of bronchospasm in experimental canine asthma. Br J Anaesth 1979;51(8):713–718.
Betts EK, Parkin CE. CEse of ketamine in an asthmatic child: a case report. Anesth Analg 1971;50(3):420–421.
Fischer MM. MMetamine hydrochloride in severe bronchospasm. Anaesthesia 1977;32(8):771–772.
Rock MJ, Reyes de la Rocha S, L’Hommedieu CS, Truemper E. Ese of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med 1986;14(5):514–516.
L’Hommedieu CS, Arens JJ. JJhe use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med 1987;16(5):568–571.
Hemming A, MacKenzie I, Finfer S. Sesponse to ketamine in status asthmaticus resistant to maximal medical treatment. Thorax 1994; 49(1):90–91.
Nehama J, Pass R, Bechtler-Karsch A, Steinberg C, Notterman DA. DAontinuous ketamine infusion for the treatment of refractory asthma in a mechanically ventilated infant: case report and review of the pediatric literature. Pediatr Emerg Care 1996;12(4):294–297.
Youssef-Ahmed MZ, Silver P, Nimkoff L, Sagy M. Montinuous infusion of ketamine in mechanically ventilated children with refractory bronchospasm. Intensive Care Med 1996;22(9):972–976.
Strube PJ, Hallam PL. PLetamine by continuous infusion in status asthmaticus. Anaesthesia 1986;41(10):1017–1019.
Jahangir SM, Islam F, Aziz L. Letamine infusion for postoperative analgesia in asthmatics: a comparison with intermittent meperidine. Anesth Analg 1993;76(1):45–49.
Sarma VJ. VJse of ketamine in acute severe asthma. Acta Anaesthesiol Scand 1992;36(1):106–107.
Petrillo TM, Fortenberry JD, Linzer JF, Simon HK. HKmergency department use of ketamine in pediatric status asthmaticus. J Asthma 2001;38(8):657–664.
Howton JC, Rose J, Duffy S, Zoltanski T, Levitt MA. MAandomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 1996;27(2):170–175.
Drazen JM, Israel E, O’Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197–206.
Adelroth E, Morris MM, Hargreave FE, O’Byrne PM. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986;315:480–484.
Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF. TFncrease in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax 2004;59:100–104.
Gaddy JN, Margolskee DJ, Bush RK, Williams VC, Busse WW. WWronchodilation with a potent and selective leukotriene-D4 antagonist in asthma patients. Am Rev Respir Dis 1992;146:358–363.
Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. TBontelukast, a once daily leukotriene receptor antagonist, in the treatment of chronic asthma. A multi-center, randomized, double-blind trial. Arch Intern Med 1998;158:1213–1220.
Dempsey OJ, Wilson AM, Sims EJ, Mistry C, Lipworth BJ. BJdditive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids. Chest 2000;117:950–953.
Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double-blind, placebo-controlled, three period, crossover study in asthmatic patients. Thorax 2000;55:260–265.
Reiss TF, Sorkness CA, Stricker W, Botto A, Busse WW, Kundu S, et al. Effects of montelukast, a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic patients treated with and without inhaled corticosteroids. Thorax 1997;52:45–48.
Silverman RA, Chen Y, Bonuccelli C. Cafirlukast improves emergency department outcomes after an acute asthma episode [abstr]. Ann Emerg Med 1999;34:S1.
Camargo CA Jr, Smithline HA, Malice MP, Green SA, Reiss TF. TF randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003;167:528–533.
Silverman RA, Nowak RM, Korenblat PE, Skobeloff E, Chen Y, Bonuccelli C, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 2004;126:1480–1489.
Mansmann HC Jr, Abboud EM, McGeady SJ. SJreatment of severe respiratory failure during status asthmaticus in children and adolescents using high flow oxygen and sodium bicarbonate. Ann Allergy Asthma Immunol 1997;78(1):69–73.
Newcomb RW, Akhter J. Jespiratory failure from asthma. A marker for children with high morbidity and mortality. Am J Dis Child 1988;142:1041–1044.
Dworkin G, Kattan M. Mechanical ventilation for status asthmaticus in children. J Pediatr 1989;114(4?Pt1):545–549.
Cox RG, Barker GA, Bohn DJ. DJfficacy, results, and complications of mechanical ventilation in children with status asthmaticus. Pediatr Pulmonol 1991;11(2):120–126.
Malmstrom K, Kaila M, Korhonen K, Dunder T, Nermes N, Klaukka T, et al. Mechanical ventilation in children with severe asthma. Pediatr Pulmonol 2001;31:405–411.
Akingbola OA, Simakajornboon N, Hadley EF Jr, Hopkins RL. Noninvasive positive-pressure ventilation in pediatric status asthmaticus. Pediatr Crit Care Med 2002;3(2):181–184.
Darioli R, Perret C. Cechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984;129:385–387.
Mazzeo AT, Spada A, Pratico C, Lucanto T, Santamaria LB. LBypercapnia: what is the limit in paediatric patients? A case of near-fatal asthma successfully treated by multipharmacological approach. Paediatr Anaesth 2004;14:596–603.
Menitove SM, Goldring RM. RMombined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med 1983; 74:898–901.
Buysee CMP, de Jongste JC, de Hoog M. Life-threatening asthma in children: treatment with sodium bicarbonate reduces PCO2. Chest 2005;127:866–870.
Sarnaik AP, Daphtary KM, Meert KL, Lieh-Lai MW, Heidemann SM. SMressure-controlled ventilation in children with severe status asthmaticus. Pediatr Crit Care Med 2004;5(2):133–138.
Wheeler DS, Clapp CR, Ponaman ML, Bsn HM, Poss WB. WBsoflurane therapy for status asthmaticus in children: a case series and protocol. Pediatr Crit Care Med 2000;1(1):55–59.
Wetzel RC. RCressure-support ventilation in children with severe asthma. Crit Care Med 1996;24(9):1603–1605.
Leatherman JW, Ravenscraft SA. SAow measured auto-positive end-expiratory pressure during mechanical ventilation of patients with severe asthma: hidden auto-positive end-expiratory pressure. Crit Care Med 1996;24:541–546.
Qvist J, Andersen JB, Pemberton M, Bennike KA. KAigh-level PEEP in severe asthma. N Engl J Med 1982;307:1347–1348.
Gay PC, Rodarte JR, Hubmayr RD. RDhe effects of positive expiratory pressure on isovolume flow and dynamic hyperinflation in patients receiving mechanical ventilation. Am Rev Respir Dis 1989;139:621–626.
Smith TC, Marini JJ. JJmpact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol 1988;65:1488–1499.
Eckmann DM. DMentilatory support by tracheal gas insufflation and chest vibration during bronchoconstriction. Crit Care Med 2000;28: 2533–2539.
Nahum A. Aracheal gas insufflation as an adjunct to mechanical ventilation. Respir Clin North Am 2002;8:171–185.
Duval EL, van Vught AJ. Status asthmaticus treated by high-frequency oscillatory ventilation. Pediatr Pulmonol 2000;30(4):350–353.
Cooper DJ, Tuxen DV, Fisher MM. MMxtracorporeal life support for status asthmaticus. Chest 1994;106:978–979.
Kukita I, Okamoto K, Sato T, Shibata Y, Taki K, Kurose M, et al. Emergency extracorporeal life support for patients with near-fatal status asthmaticus. Am J Emerg Med 1997;15:566–569.
Mabuchi N, Takasu H, Ito S, Yamada T, Arakawa M, Hatta M, et al. Successful extracorporeal lung assist (ELCA) for a patient with severe asthma and cardiac arrest. Clin Intensive Care 1991;2:292–294.
MacDonnell KF, Moon HS, Sekar TS, Ahlwalia MP. MPxtracorporeal membrane oxygenator support in a case of severe status asthmaticus. Ann Thorac Surg 1981;31:171–175.
Sakai M, Ohteki H, Doi K, Narita Y. Ylinical use of extracorporeal lung assist for a patient in status asthmaticus. Ann Thorac Surg 1996;62: 885–887.
Tajimi K, Kasai T, Nakatani T, Kobayashi T. Txtracorporeal lung assist for patient with hypercapnia due to status asthmaticus. Intensive Care Med 1988;14:588–589.
Meyer NE, Schotz S. Selief of intractable bronchial asthma with cyclopropane anesthesia: report of case. J Allergy 1939;10:239–240.
Hirshman CA, Edelstein G, Peetz S, Wayne R, Downes H. Hechanism of action of inhalational anesthetics on airways. Anesthesiology 1982;56:107–111.
Park KW, Dai HB, Lowenstein E, Kocher ON, Sellke FW. FWsoflurane- and halothane-mediated dilation of distal bronchi in the rat depends on the epithelium. Anesthesiology 1997;86:1078–1087.
Park KW, Dai HB, Lowenstein E, Sellke FW. FWpithelial dependence of the bronchodilatory effect of sevoflurane and desflurane in rat distal bronchi. Anesth Analg 1998;86:646–651.
Gold MI, Helrich M. Mulmonary mechanics during general anesthesia: V. Status asthmaticus. Anesthesiology 1970;32:422–428.
Echeverria M, Gelb AW, Wexler HR, Ahmad D, Kenefick P. Pnflurane and halothane in status asthmaticus. Chest 1986;89:152–154.
O’Rourke PP, Crone PK. PKalothane in status asthmaticus. Crit Care Med 1982;10:341–343.
Saulnier FF, Durocher AV, Deturck RA, Lefebvre MC, Wattel FE. FEespiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med 1990;16:104–107.
Eger EI. EIsoflurane: A review. Anesthesiology 1981;55:559–576.
Pearson J. Jrolonged anesthesia with isoflurane. Anesth Analg 1985;64:92–93.
Parnass SM, Feld JM, Chamberlin WH, Segil LJ. LJtatus asthmaticus treated with isoflurane and enflurane. Anesth Analg 1987;66:193–195.
Rice M, Hatherill M, Murdoch IA. IAapid response to isoflurane in refractory status asthmaticus. Arch Dis Child 1998;78(4):395–396.
Best A, Wenstone R, Murphy P. Prolonged use of isoflurane in asthma. Can J Anaesth 1994;41:452–453.
Johnston RG, Noseworthy TW, Friesen EG, Yule HA, Shustack A. Asoflurane therapy for status asthmaticus in children and adults. Chest 1990;97(3):698–701.
Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL. FLrolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 1986;14: 832–833.
Otte RW, Fireman P. Psoflurane anesthesia for the treatment of refractory status asthmaticus. Ann Allergy 1991;66(4):305–309.
Mazze RI, Calverly RK, Smith NT. NTnorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. Anesthesiology 1977;46:265–271.
Truog RD, Rice SA. SAnorganic fluoride and prolonged isoflurane anesthesia in the intensive care unit. Anesth Analg 1989;69:843–845.
Spencer EM, Willats SM, Prys-Roberts C. Plasma inorganic fluoride concentrations during and after prolonged (>24?h) isoflurane sedation: effect on renal function. Anesthesiology 1991;73:731–737.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London
About this chapter
Cite this chapter
Wheeler, D.S., Page, K., Shanley, T.P. (2009). Status Asthmaticus. In: Wheeler, D., Wong, H., Shanley, T. (eds) The Respiratory Tract in Pediatric Critical Illness and Injury. Springer, London. https://doi.org/10.1007/978-1-84800-925-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-84800-925-7_15
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84800-924-0
Online ISBN: 978-1-84800-925-7
eBook Packages: MedicineMedicine (R0)